Literature DB >> 1500440

Involvement of the consensus sequence motif at coil 2b in the assembly and stability of vimentin filaments.

P D Kouklis1, P Traub, S D Georgatos.   

Abstract

Nearly all intermediate filament (IF) proteins share two sequence motifs located at the N- and the C-terminal ends of their helical rod domain ('coil 1a' and 'coil 2b', respectively). To examine the structural role of the coil 2b motif, we have performed in vitro assembly studies and in vivo microinjection experiments employing two site-specific reagents: (a) a 20-residue synthetic peptide (C-2) representing the conserved motif itself and (b) a monoclonal antibody (anti-IFA) that recognises an epitope within the conserved coil 2b sequence. We demonstrate here that vimentin protofilaments, when induced to assemble in the presence of C-2 or anti-IFA, show a lower propensity to polymerise and yield various abberant structures. The few filaments that are formed under these conditions appear much shorter than normal IFs and are unravelled or aggregated. Furthermore, when preformed vimentin filaments are exposed to C-2 or anti-IFA, most of the normal IFs are converted into shorter filamentous forms that possess an abberant morphology. None of these effects is seen when vimentin subunits are coincubated with control peptides. Microinjection of anti-IFA into the cytoplasm of interphasic 3T3 cells provokes collapse of vimentin IFs into a juxtanuclear mass and formation of numerous amorphous aggregates distributed throughout the cytoplasm. These two effects are not seen when the anti-IFA is microinjected into the cell nucleus. Our results provide experimental evidence supporting previous suggestions for a role for the conserved coil 2b sequence in filament assembly. We propose that this region is interacting with other sites along the vimentin molecule and that these interactions are essential for proper protofilament-protofilament alignment and filament stability.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500440     DOI: 10.1242/jcs.102.1.31

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  Intracellular delivery of proteins into mouse Müller glia cells in vitro and in vivo using Pep-1 transfection reagent.

Authors:  Minhua H Wang; Laura J Frishman; Deborah C Otteson
Journal:  J Neurosci Methods       Date:  2008-11-17       Impact factor: 2.390

2.  The function of intermediate filaments in cell shape and cytoskeletal integrity.

Authors:  R D Goldman; S Khuon; Y H Chou; P Opal; P M Steinert
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

Review 3.  Insights into the beaded filament of the eye lens.

Authors:  Ming-Der Perng; Qingjiong Zhang; Roy A Quinlan
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

4.  Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis.

Authors:  Paola Bargagna-Mohan; Riya R Paranthan; Adel Hamza; Neviana Dimova; Beatrice Trucchi; Cidambi Srinivasan; Gregory I Elliott; Chang-Guo Zhan; Daniel L Lau; Haiyan Zhu; Kousuke Kasahara; Masaki Inagaki; Franca Cambi; Royce Mohan
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

5.  The roles of the rod end and the tail in vimentin IF assembly and IF network formation.

Authors:  M B McCormick; P Kouklis; A Syder; E Fuchs
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

6.  Separation of Coiled-Coil Structures in Lamin A/C Is Required for the Elongation of the Filament.

Authors:  Jinsook Ahn; Soyeon Jeong; So-Mi Kang; Inseong Jo; Bum-Joon Park; Nam-Chul Ha
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

7.  Bovine filensin possesses primary and secondary structure similarity to intermediate filament proteins.

Authors:  F Gounari; A Merdes; R Quinlan; J Hess; P G FitzGerald; C A Ouzounis; S D Georgatos
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.